- Home
- EXEL vs BNT Comparison
EXEL vs BNT Comparison
Compare EXEL & BNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- BNT
- Stock Information
- Founded
- EXEL 1994
- BNT 2020
- Country
- EXEL United States
- BNT Bermuda
- Employees
- EXEL N/A
- BNT N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- BNT
- Sector
- EXEL Health Care
- BNT
- Exchange
- EXEL Nasdaq
- BNT Nasdaq
- Market Cap
- EXEL 9.4B
- BNT 10.2B
- IPO Year
- EXEL 2000
- BNT N/A
- Fundamental
- Price
- EXEL $36.85
- BNT $58.68
- Analyst Decision
- EXEL Buy
- BNT
- Analyst Count
- EXEL 18
- BNT 0
- Target Price
- EXEL $37.24
- BNT N/A
- AVG Volume (30 Days)
- EXEL 2.5M
- BNT 9.3K
- Earning Date
- EXEL 02-11-2025
- BNT 02-13-2025
- Dividend Yield
- EXEL N/A
- BNT 0.61%
- EPS Growth
- EXEL 170.77
- BNT 28.92
- EPS
- EXEL 1.76
- BNT 7.05
- Revenue
- EXEL $2,168,701,000.00
- BNT $14,103,000,000.00
- Revenue This Year
- EXEL $5.36
- BNT N/A
- Revenue Next Year
- EXEL $10.59
- BNT N/A
- P/E Ratio
- EXEL $20.87
- BNT $8.49
- Revenue Growth
- EXEL 18.49
- BNT 100.90
- 52 Week Low
- EXEL $20.14
- BNT $38.25
- 52 Week High
- EXEL $37.59
- BNT $62.72
- Technical
- Relative Strength Index (RSI)
- EXEL 65.59
- BNT N/A
- Support Level
- EXEL $34.01
- BNT N/A
- Resistance Level
- EXEL $35.46
- BNT N/A
- Average True Range (ATR)
- EXEL 1.09
- BNT 0.00
- MACD
- EXEL 0.36
- BNT 0.00
- Stochastic Oscillator
- EXEL 95.70
- BNT 0.00
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About BNT Brookfield Wealth Solutions Ltd.
Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. It is organized into three reporting segments: Direct Insurance, Reinsurance, and Pension Risk Transfer (PRT).